Download:
pdf |
pdfPPHF 2014: Lead Poisoning
Prevention - Childhood Lead
Poisoning Prevention – financed
solely by 2014 Prevention and Public
Health Funds
CDC-RFA-EH14-1408PPHF14
National Center for Environmental
Health
Version 2.0
Issued 08/30/2013
Contents
Part I. Overview Information ........................................................................................................................ 1
A.
Federal Agency Name .................................................................................................... 2
B.
Funding Opportunity Title .............................................................................................. 2
C.
Announcement Type: New—Type 1 .............................................................................. 2
D.
Agency Funding Opportunity Number ........................................................................... 2
E.
Catalog of Federal Domestic Assistance (CFDA) Number .............................................. 2
F.
Dates .............................................................................................................................. 2
G.
Executive Summary........................................................................................................ 2
Part II. Full Text ............................................................................................................................................. 4
A.
Funding Opportunity Description .................................................................................. 4
B.
Award Information....................................................................................................... 20
C.
Eligibility Information................................................................................................... 21
D.
Application and Submission Information..................................................................... 22
E.
Application Review Information .................................................................................. 34
F.
Award Administration Information.............................................................................. 36
G.
Agency Contacts........................................................................................................... 45
H.
Other Information ........................................................................................................ 46
I.
Glossary ........................................................................................................................ 46
Part I. Overview Information
Page 1
Applicants must go to the synopsis page of this announcement at www.grants.gov and click on
the “Send Me Change Notifications Emails” link to ensure they receive notifications of any
changes to CDC-RFA-EH 14-1408. Applicants also must provide an e-mail address to
www.grants.gov to receive notifications of changes.
A. Federal Agency Name:
Centers for Disease Control and Prevention (CDC)
B. Funding Opportunity Title:
PPHF 2014: Lead Poisoning Prevention- Childhood Lead Poisoning Prevention---financed solely
by 2014 Prevention and Public Health Funds
C. Announcement Type: New—Type 1
This announcement is only for nonresearch domestic activities supported by CDC. If research is
proposed, the application will not be considered. Research for this purpose is defined at
www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-researchnonresearch.pdf.
D. Agency Funding Opportunity Number:
CDC-RFA-EH14-1408PPHF14
E. Catalog of Federal Domestic Assistance (CFDA) Number:
93.753
F. Dates:
1. Letter of Intent (LOI) Deadline: June 30, 2014 via email to Kimball F. Credle, Project
Officer, [email protected]
2. Application Deadline: July 22, 2014, 11:59 p.m. U.S. Eastern Standard Time, on
www.grants.gov
3. Informational conference call for potential applicants: n/a
G. Executive Summary:
1. Summary Paragraph:
An estimated 535,000 children in the United States have blood lead levels (BLLs) at or
Page 2
above the reference value for blood lead established by CDC in 2012 (5 µg/dL). Of these,
150,000 children’s levels are ≥ 10 µg/dL. These children are at grave risk for the
intellectual, behavioral, and academic deficits caused by lead. The primary source of
lead exposure for children is their homes; some 38 million homes in the United States
have lead-based paint hazards that can result in childhood lead poisoning. Low-income
and minority children bear a disproportionate burden of this condition caused by
unhealthy housing. In addition, some areas of the United States report that as many as
35% of children identified with high BLLs have been exposed to lead via sources other
than lead-based paint in their homes (e.g., items decorated or made with lead such as
toys, imported cosmetics, pottery, and candy). This FOA goes beyond historical efforts
to support childhood lead poisoning surveillance activities, and it will award
approximately $11 million through cooperative agreements to use surveillance data to
identify the highest risk areas and target appropriate population-based prevention
interventions wherever needs are identified. Examples of such interventions include
housing rehabilitation, enforcement of housing and health codes, engagement with
health care systems, public and health care provider education campaigns related to
lead contamination through other sources (e.g., imported items), and other educational
and public health activities.
a. Eligible Applicants (select one): limited competition
b. FOA Type (select one): cooperative agreement
c. Approximate Number of Awards: Up to 41
d. Annual Project Period Funding: $11,000,000
Total Project Period Funding: $33 million (“Throughout the project period, CDC will
continue the award based on the availability of funds, the evidence of satisfactory progress by
the awardee (as documented in required reports), and the determination that continued funding
is in the best interest of the federal government. The total number of years for which federal
support has been approved (project period) will be shown in the “Notice of Award.” This
information does not constitute a commitment by the federal government to fund the entire
period. The total project period comprises the initial competitive segment and any subsequent
non-competitive continuation award(s). Funding is subject to change based on CDC budgets and
priorities and emerging public health issues and outbreaks).
e. N/A
f. Average One Year Award Amount: Approximate average award: $250,000, each
award not to exceed $500,000
Page 3
g. Number of Years of Award: 12 months (3 years)
h. Approximate Date When Awards will be Announced: September 1, 2014
i. Cost Sharing and/or Matching Requirements: n/a
Part II. Full Text
A. Funding Opportunity Description
1.
Background
An estimated 535,000 children in the United States have BLLs at or above the reference value
for blood lead established by CDC in 2012 (5 µg/dL). Of these, 150,000 children’s levels are ≥10
µg/dL. These children are at grave risk for the intellectual, behavioral, and academic deficits
caused by lead. The primary source of lead exposure for children is their homes; some 38
million homes in the United States have lead-based paint hazards that can result in childhood
lead poisoning. Low-income and minority children bear a disproportionate burden of this
condition caused by unhealthy housing. In addition, some areas of the United States report
that as many as 35% of children identified with high BLLs have been exposed to lead via
sources other than lead-based paint in their homes (e.g., items decorated or made with lead
such as toys, imported cosmetics, pottery, and candy).
From 1990 to 2012, CDC awarded funds to state and local health departments to support
childhood lead poisoning prevention programs. In 2009, this mission was expanded to include
a healthy homes initiative that addressed multiple childhood diseases and injuries in the home
but with a continued focus on reaching the Healthy People goal of eliminating childhood lead
poisoning. At reduced levels in 2013, CDC focused on advising state and local agencies and
stakeholders in healthy homes and lead poisoning prevention, administered epidemiological
and laboratory expertise and monitored trends in childhood blood lead levels from states that
provided data.
This FOA goes beyond historical efforts to support childhood lead poisoning surveillance
activities, and it will award approximately $11 million through cooperative agreements to use
surveillance data to identify the highest risk areas and implement appropriate populationbased prevention interventions wherever needs are identified. Examples of such interventions
Page 4
include housing rehabilitation, enforcement of housing and health codes, engagement with
health care systems, public and health care provider education campaigns related to lead
contamination through other sources (e.g., imported items), and other educational and public
health activities.
Data may also be used to designate areas as ‘lead safe’ and qualify applicants to apply for a
universal blood lead testing waiver through Medicaid. The Center for Medicare and Medicaid
Services (CMS) in collaboration with CDC has developed a mechanism for jurisdictions to apply
to waive the universal blood lead testing requirement for children enrolled in Medicaid. This
mechanism recognizes that some areas of the country are lead safe (have historically had low
BLL and/or environmental lead levels below regulatory thresholds). These areas might qualify
for such a waiver but lack the necessary evidence to allow them to qualify.
a. Statutory Authorities:
This program is authorized under Sections 317(k) (2) and 317B(b) of the Public Health Service
Act, (42 U.S.C. Section 247b (k) (2)] and 247b-3(b)), as amended; Section4002 of the Patient
Protection and Affordable Care Act of 2010 (ACA), P. L. 111-148, (42 U.S.C. Section 300u-11).
The funding provided by the Prevention and Public Health Fund (PPHF) established by the ACA,
provides an important opportunity for states, counties, territories, tribes, and community
organizations to advance public health across the lifespan and reduce health disparities.
In 2014, with PPHF assistance, this FOA will support surveillance and population-based
interventions to reduce risks responsible for one of the leading causes of developmental
disability in children and to prevent and control sources of lead in children’s environments
before their BLLs become high.
b. Healthy People 2020:
This announcement addresses the Healthy People 2020 focus areas of environmental health,
public health infrastructure, and education and community-based programs by providing data
management and surveillance support. Through the surveillance activities of its grantees, CDC
will be able to quantify BLLs in children and the percent of children exposed to lead hazards.
These data will be used to determine where population and community-based interventions
may be implemented and will enable CDC to track national progress in reducing lead exposures
in children.
c. Other National Public Health Priorities and Strategies:
The childhood lead poisoning surveillance system serves as a critical component of the Office
of the Surgeon General’s “Call to Action to Promote Healthy Homes,” which highlights lead
Page 5
hazard control in the home as one of the key interventions ready for broad-scale
implementation (www.surgeongeneral.gov/library/calls). CDC also works closely with HUD,
EPA, DOE, HRSA to reduce lead and promote safe and healthy home environment.
http://portal.hud.gov/hudportal/documents/huddoc?id=stratplan_final_11_13.pdf
The National Prevention Strategy includes the creation of communities that promote health
and wellness through prevention, including those that ensure safe and affordable housing free
of hazards, such as secondhand smoke, lead, and toxic chemicals, as one of its key
recommendations (http://www.surgeongeneral.gov/initiatives/prevention/strategy/healthyand-safe-community-environments.html).
d. Relevant Work:
This FOA builds on the successes of CDC programs from 1990 to 2012 that provided assistance
to state and local health departments supporting childhood lead poisoning surveillance and
prevention. For further information, applicants are encouraged to consult
www.cdc.gov/nceh/lead.
1.
CDC Project Description
This new FOA goes beyond historical efforts to collect and provide data on the nature
and extent of high BLLs and will award approximately $11 million through cooperative
agreements to use surveillance data to identify the highest risk areas and implement
appropriate population-based prevention interventions wherever needs are identified.
Examples of such interventions include housing rehabilitation, enforcement of housing
and health codes, engagement with health care systems, public and health care
provider education campaigns related to lead contamination through other sources
(e.g., imported items), and other public health activities.
Specifically, applicants will conduct surveillance and analyze and use these surveillance
data to
Identify remaining at-risk geographic areas and ensure that appropriate
population and community-based, primary prevention interventions are
targeted to the highest risk areas or subpopulations: e.g., housing
rehabilitation, enforcement of housing and health codes, engagement with
health care systems, public and health care provider education campaigns
related to lead contamination through other sources (e.g., imported items), and
other educational and public health activities,
(As noted in Section E.1.b., Application Review Information, greater rating
Page 6
emphasis will be placed on applicant’s ability to ensure that appropriate
population and community-based interventions are targeted to the highest risk
areas or subpopulations).
identify children at-risk to target testing and resources,
identify emerging sources of exposure and inform strategic plans to remove or
reduce sources,
evaluate the timeliness and efficacy of case management services available to
children with lead poisoning and work with inspectors and risk assessors to
ensure safe living environments,
target pediatric health care provider education efforts, and,
serve as the basis for a waiver for universal blood lead testing of children
enrolled in Medicaid (if appropriate).
Funded applicants may benefit from the existence of any regulations that require
electronic reporting of blood and environmental lead tests, as well as laws and
regulations that control or eliminate sources of lead in the environments of children
less than 6 years of age. Applicants must provide data to CDC. If a surveillance system
is not already being implemented in their jurisdictions, funded applicants are
encouraged to adopt the Healthy Homes and Lead Poisoning Surveillance System
(HHLPSS) as a common platform. Funded applicants who do not adopt HHLPSS are still
required to collect data related to blood lead testing, lead poisoning case management,
and environmental lead investigations and are required to report such data to CDC.
To assist in the development and implementation of appropriate interventions,
collected data shall integrate or interface with other
maternal child and environmental public health databases (e.g., immunization
registries; Adult Blood Lead Epidemiology and Surveillance [ABLES];
Environmental Public Health Tracking Network; Medicaid; HRSA Title V; Early
Childhood Home Visiting Programs; and Special Supplemental Nutrition
Program for Women, Infants and Children [WIC])
state and local housing, education, and environmental quality authorities; and
housing data including that for housing code enforcement agencies and publicly
owned or subsidized properties and Housing and Urban Development (HUD)
collaborative programs.
Funded applicants will manage, analyze, and interpret individual jurisdictional
Page 7
surveillance data and present and disseminate trends and other important public
health findings in annual reports. Annual reports will include:
data on blood lead testing and follow-up of children identified with high BLLs,
lead hazard identification and control and abatement activities in awardees’
jurisdictions, and
proposed interventions for high-risk areas.
a. Approach:
The logic model described in Figure 1 depicts the lines of communication and responsibility of
CDC staff and state and local partners in conducting the surveillance activities and achieving
the related outcomes.
Page 8
Figure 1.
Strategies
Activities
Technical/organizational
Identify and implement
appropriate
hardware/software
Operate HHLPPS or equivalent
collect and evaluate data and
establish reporting system
Share and disseminate data to
partners and public
Implement a staff
training/meeting plan
Implement an evaluation
strategy and measures
Health-impact related
Implement screening plan
Implement follow-up care
plan
Implement
participation/involvement
program
Collaborate with
CDC/partners
Implement community-based
plan for underserved
Outputs
Technical/organizational
•
surveillance/tracking
system
•
sufficient
hardware/software/staff
•
data cleaning plan
•
data dissemination plan
•
reporting system
•
program evaluation
procedure/measures
Outcome
•
•
•
•
•
Health-impact related
•
follow-up care guidance
•
data dissemination plan
for partners
•
follow-up prevention
and control strategy
guidance
•
promotion and
communication plan
•
Monitoring & Evaluation
systems (MEs)
Short- and Mid-Term
Data used by federal
agencies/PH decision-makers to
target actions and develop
appropriate interventions.
Program/ partners implement
individual and community-based
strategies
Strategies effective in
controlling or eliminating lead
sources
Increased support of public,
professionals , leaders for
programs and action on lead
Leveraged resources to replicate
and conduct additional
population-based interventions.
Page 8
•
•
•
•
Longer-Term
Reduction in number
of children with BLLs
at or above reference
value
Decreased hazards in
housing and emerging
sources
Increased support of
primary prevention
strategies
Reduced healthcare,
special education and
juvenile justice costs
j. Problem Statement:
An estimated 535,000 children in the United States have BLLs at or above the reference value
for blood lead established by CDC in 2012 (5 µg/dL). Of those 150,000 children’s levels are ≥
10 µg/dL. These children are a grave risk for the intellectual, behavioral, and academic
deficits caused by lead. Primary source of lead exposure for children are their homes; some
38 million homes in the United States have lead-based paint hazards that can result in
childhood lead poisoning. Low-income and minority children bear a disproportionate burden
of this condition caused by unhealthy housing. However, areas of the United States report
that as many as 35% children identified with elevated BLLs have been exposed to lead via
sources other than lead-based paint in their homes (e.g., items decorated or made with lead
such as toys, imported cosmetics, pottery, and candy).
ii. Purpose:
The purpose of these activities is to assist in building surveillance capacity to aid in preventing
and, ultimately, eliminating childhood lead poisoning as a major public health problem. This
FOA goes beyond historical efforts to support childhood lead poisoning surveillance activities,
and it will award approximately $11 million through cooperative agreements to use
surveillance data to identify the highest risk areas and implement appropriate populationbased prevention interventions wherever needs are identified. Examples of such
interventions include housing rehabilitation, enforcement of housing and health codes,
engagement with health care systems, public and health care provider education campaigns
related to lead contamination through other sources (e.g., imported items), and other
educational and public health activities. Data may also be used to designate areas as ‘lead
safe’ and qualify applicants to apply for a universal blood lead testing waiver through
Medicaid.
The surveillance data on the nature and extent of high BLLs should be used to
identify remaining at-risk geographic areas to target implementation of populationbased, primary prevention interventions (e.g., housing rehabilitation, enforcement of
housing and health codes, engagement with health care systems, public and health
care provider education campaigns related to lead contamination through other
sources (e.g., imported items), and other educational and public health activities) and
evaluate the timeliness and efficacy of case management of children identified with
high BLLs
iii. Outcomes:
The intended ultimate outcome of this cooperative agreement is to decrease exposure to lead hazards
and reduce BLLs among children. Applicants are expected to implement a childhood lead poisoning
Page 9
surveillance system that can report quarterly on the number of children who are exposed to lead in
housing, the number of houses that are identified with lead, and the nature and extent of lead in
housing. Applicants are also expected to identify underserved high-risk populations or emerging sources
of lead and use data to target appropriate interventions and/or to provide evidence of designated ‘lead
safe’ areas. Additionally, applicants will provide address-specific information to CDC and state and local
housing agencies and other stakeholders that allow for targeting of resources to the most distressed
housing and other lead exposure sources.
Key activities, outputs, and outcomes are noted in the logic model. A series of outcomes are presented
later in this section. These will be achieved by effective implementation by the awardee of a set of
technical/organizational outputs, and a set of health-impact related outputs, as follows:
Technical/organizational outputs:
ongoing sustainable childhood lead poisoning surveillance/tracking system in grantees’
jurisdictions that collects person-specific and address-specific data, including multiple
laboratory test results over various years. This is to assure the periodic screening of children
who are exposed to lead and prevent multiple counting of children with more than one blood
lead test. This assures the periodic screening of children who are exposed to lead and
prevents double counting of children with multiple tests.
data must be reported to CDC through HHLPPS or a state-specific data system. Applicants
must demonstrate that its lead surveillance reporting system is or will qualify it for the
exception accorded under 5 CFR§1320.3(b)(3) –that is that such data are already
collected by state, local or tribal governments in the absence of a federal requirement.
•
hardware, software, and sufficient staff to address every aspect of surveillance including data
collection, data entry, data management, data analysis, epidemiological support, and information
technology support.
•
ongoing data cleaning plan to address duplicate records and correct errors (i.e., laboratory result
dates, reuse of patient IDs, address format problems) identified during data processing for CDC quarterly
submissions. Data cleaning should be undertaken regularly and errors identified during data processing
should be corrected before the next quarterly submission.
•
ongoing data dissemination plan that reports all required data elements and surveillance activity
to CDC and to state and other federal partners on a quarterly basis and/or annually as required.
•
reporting system that adheres to the CDC reporting requirements. Applicants are encouraged to
refer to www.cdc.gov/nceh/lead for a list of reporting requirements.
•
program evaluation procedure that provides appropriate indicators for periodically determining
Page 10
and measuring the effectiveness and success of the cooperative agreement activities in achieving the
stated program outcomes.
Health-impact related outputs
•
guidance for the follow-up care of children who are identified with elevated BLLs that includes
evaluation of timeliness and efficacy of these activities.
•
program to ensure that the data received federal agencies and public health officials and
decision-makers allows them (a) to target actions to areas where the risk for childhood lead poisoning is
highest and (b) to develop appropriate population based interventions. For example, state-based blood
lead surveillance data are critical to federal efforts to enforce the lead paint disclosure rule in properties
where many children have suffered high BLLs.
•
guidance for follow-up care of children who are identified with high BLLs that includes evaluation
of both individual and community-based strategies to control or eliminate lead sources before other
children are exposed to these sources. For example, in some places small-area population-based
surveillance has been used to identify parents who are exposed to lead at work, bring lead dust home,
and expose their children. Programs then work with the families to educate them to the dangers of takehome lead exposure and with the facility to ensure that lead-safe work practices are in place.
•
ongoing promotion and information dissemination program that will encourage action among
the general public, professionals , and other leaders in supporting programs to prevent childhood lead
poisoning. For example, many states have executed memoranda of understanding with local housing
authorities to link blood lead data with information on publicly-owned or subsidized properties to
ensure the properties are lead safe. Other jurisdictions have used surveillance data to inform community
leaders and policy makers. The data has been important to demonstrating the need for measures to
make privately-owned housing lead safe.
•
system that measures progress toward elimination of elevated BLLs as a public health problem in
local jurisdictions/defined geographic areas.
Health-impact related outcomes
The technical/organizational and health-impact related outputs described above will, during the project
period, drive the following outcomes.
•
data are used by federal agencies and public health officials and decision-makers to (a) to target
actions to areas where the risk for childhood lead poisoning is highest and (b) to develop
appropriate population based interventions.
•
program and partners implement and evaluate both individual and community-based strategies
Page 11
to control or eliminate lead sources before other children are exposed to these sources Followup measures associated with high BLLs are effective in controlling or eliminating sources of lead
in children’s environments.
general public, professionals, and other leaders increase support for programs to prevent
childhood lead poisoning and take appropriate action. Increased support among decision makers
and the public for efforts to support primary prevention of childhood lead poisoning through
control or elimination of lead sources; . Action taken by professionals and the public based on
findings of underserved high-risk populations and areas.
Leveraged resources to replicate and conduct additional population-based interventions.
Defined progress toward elimination of elevated BLLs in the jurisdiction or geographic area; no
children have BLLs at or above the reference value for BLL, currently 5 µg/dL.
Establishment of a system that measures progress toward elimination of elevated BLLs as a public health
problem in local jurisdictions/defined geographic areas.
iv. Funding Strategy:
Each award is not to exceed $500,000.
v. Strategies and Activities:
Applicants are expected to implement a childhood lead poisoning surveillance system consistent with
CDC standards and undertake the following technical/organizational and health-impact driven activities
depicted in the logic model and which will drive the outputs in the logic model and described in the prior
section. Applicants are encouraged to refer to www.cdc.gov/nceh/lead for a list of reporting
requirements.
Technical/organizational activities: The following activities help ensure the creation and sustainment of
the technical/organizational outputs described above.
•
Use appropriate hardware and software to support the surveillance system.
•
Operate HHLPPS, operate a comparable blood lead surveillance system, or modify an existing
system that will collect, compile, and track blood lead data and lead hazards data.
•
Include information on how data will be collected, evaluated, reported, shared with partners,
and disseminated to the public.
•
Implement a procedure for reporting program achievements and progress in accordance with
the CDC reporting requirements and schedule.
Page 12
Implement a training and meeting attendance plan for applicants’ staff that includes lead
poisoning prevention training and attendance at a minimum of one national lead poisoning
prevention meeting each year. This includes applicants paying for training/meeting travel as
required and this information should be included in the budget plan.
•
Implement an evaluation strategy with appropriate indicators or measures to determine and
report program effectiveness.
Health impact related activities: The following activities help ensure the creation and sustainment of the
health impact-related outputs described above.
•
lead.
Implement a plan that assures periodic screening of children who are potentially exposed to
•
Implement a plan that provides follow-up care for children who are identified with elevated BLLs
including a plan for reimbursement for clinical care, case management/home visits, and environmental
inspections and enforcement that is consistent with CDC recommendations.
•
Implement a program that ensures meaningful (active) involvement of affected populations
during initial phases of the decision-making process, an essential step to addressing health and housing
inequities among disparate populations. For example, some programs have integrated community
members into their strategic planning processes.
Work with CDC and other partners including state housing agencies, stakeholders, educators,
and child health professionals to support local decision making and targeting of state and local
resources to the unhealthiest housing and the highest risk populations as evidenced by
memoranda of understanding, joint outside funding applications, and data-sharing agreements.
Develop data sharing agreements with school districts, WIC, code enforcement agencies, and juvenile
justice agencies
•
Implement a community-based plan to address the needs of underserved populations and
emerging sources of lead or to designate certain areas as lead safe based on small-area populationbased surveillance (e.g., develop culturally competent health education materials to alert recent
immigrant families to lead in traditional medicine, cosmetics, or spices; alert state and federal agencies
with regulatory authority to emerging lead sources).
1. Collaborations – Applicants are required to build on ongoing strategic partnerships (or
establish new ones) in their jurisdictions that may have a role in the FOA outcomes.
Historical or current initiatives and future collaborative efforts are to be included in this
Page 13
area.
a. With CDC-funded programs:
Many applicants will have already established strategic partnerships under previous
CDC Healthy Homes and Lead Poisoning Prevention cooperative agreements.
Applicants will not duplicate efforts but will reinforce and build on them. Those
applicants must include that information even if previously funded. Applicants will
also work with other CDC-funded programs in their jurisdictions that may have a role
in the FOA outcomes.. Examples include but are not limited to the Environmental
Public Health Tracking Program and the National Institute of Occupational Safety and
Health’s Adult Blood Lead Epidemiology Program (ABLES).
b. With organizations external to CDC:
Applicants are required to work with relevant organizations external to CDC such as
HRSA Home Visiting, Healthy Start and Title V Grantees
community organizations,
state and local health and housing agencies,
academic institutions,
hospitals and healthcare systems, and
others entities involved in implementation of program activities.
Partners should also include
community-based, nonprofit and/or faith-based organizations and groups and
educators and
regional and federal agencies including the U.S. Department of Housing and
Urban Development. Collaborations- Strategies should be implemented for
leveraging resources that include funds from other allowable federally funded
programs and/or state, local, charity, nonprofit or for-profit entities, or
internal agency resources.
2. Target Populations:
The focus of the surveillance program includes children less than 6 years of age, with
special emphasis on children under the age of 3 years. Priority should be given to children
disproportionately at risk, including children in low-income households, minority and
recent immigrant children, and children in areas where the prevalence of lead is high.
Page 14
The applicant must describe:
How the burden of lead hazards disproportionately affects children of certain
races and ethnicities and varies within the current jurisdiction.
How low-income, minority children are more likely to live in homes with lead
hazards, as well as be exposed to other sources of lead.
How a particularly high-risk geographic area was selected (demographic
information, historic high BLLs in population, underserved population, other
factors).
How partnerships, policies, and strategic planning will be undertaken to
implement population and community-based strategies to lead hazards identified
by small-area population-based surveillance or case management.
Inclusion: N/A
b. Evaluation and Performance Measurement:
i. CDC Evaluation and Performance Measurement Strategy:
The evaluation and performance measurement strategy will address the implementation of the
activities/outputs and the progress on the outcomes depicted in the logic model and presented in more
detail in the approach narrative. Programs will be required to report this information to CDC annually.
The format used to report this information will be the format described later in the work plan section.
Key monitoring and evaluation questions related to the key activities/outputs include the following:
Measures for: Technical/organizational activities/outputs
o
The surveillance system collects address-specific and child-specific data on blood and
environmental lead levels.
o
The proposed surveillance system is compatible with CDC HHLPSS.
o
Blood lead data will be reported and meet the intended benchmarks for sound reporting found
at www.cdc.gov/nceh/lead.
o
The program will be able to maintain 100% electronic reporting of blood lead data from
laboratories.
o
Ninety-five percent of the data received by CDC is free of errors and missing information.
o
Data-sharing agreements are in place with housing, education, and other partner organizations.
o
The total number of BLL results received annually is described.
Page 15
o
Processing of BLL results is timely.
Measures for: Health impact related activities/outputs:
•
Referrals to the appropriate agencies/organizations are made.
•
Follow-up measures associated with high BLLs are effective in controlling or eliminating sources of lead in
children’s environments.
Criteria used to identify high risk areas are justified.
Community based partners (health care providers, community organizations, nongovernment organizations
[NGOs], others) and/or universities/colleges agree to participate in preparing for and assisting in populationbased surveillance and targeted interventions.
The mechanism for BLL measurement and reporting of individual BLL results back to parents, health care
providers and state authorities is described.
Management of children identified with elevated BLLs is consistent with CDC guidelines.
Resources (e.g., GIS software) and data (e.g., blood lead surveillance, census, and tax assessor data) are used
to analyze and report data.
Overall results are provided to pediatric health care providers, decision-makers, community leaders, and
community organizations.
[Production, reporting, and dissemination of evaluation results related to progress in improved health of
children.
Measures for: Outcomes:
o
Defined progress toward elimination of elevated BLLs as a public health problem in the local jurisdiction
or geographic area; no children have BLLs at or above the reference value for BLL, currently 5 µg/dL.
o
Action taken by professionals and the public based on findings of underserved high-risk populations and
areas.
o
Leveraged resources to replicate and conduct additional population-based interventions.
ii. Applicant Evaluation and Performance Measurement Plan:
Applicants must provide an overall evaluation and performance measurement plan based on the CDC
evaluation and performance measurement strategy. (An electronic expandable template is available on
the CDC Healthy Homes and Lead Poisoning Prevention website [www.cdc.gov/nceh/lead]).
•
Awardee Evaluation and Performance Measurement Plan:
Page 16
A more-detailed evaluation and performance measurement plan for the entire project may be
developed by awardees with support of CDC as part of first-year project activities.
c. Organizational Capacity of Awardees to Execute the Approach:
Applicant will provide curriculum vitae for existing key personnel (or job descriptions for
planned key personnel). Key personnel must have the level of education, experience, and/or
skills necessary to successfully implement and complete the project. The organization capacity
statement should describe how the applicant agency is organized to carry out the
requirements of this announcement, the nature and scope of its work, and/or its capabilities.
Applicants should include a detailed description of their experience, program management
components, and readiness to establish working agreements, as well as letters of intent or
contracts with collaborating or partner entities and a plan for long-term sustainability of the
project.
d. Work Plan:
A work plan is a program management tool that provides program direction and guidance. It is
designed for program planning and implementation, as well as monitoring progress made
toward reaching program goals and objectives.
Applicants must have a work plan with goals and objectives that are aligned with the outcomes
specified in the logic model and in the approach narrative. These goals and objectives should
be driven by the specific activities and outputs presented in the logic model and described in
the approach narrative. Activities should emphasize high-risk populations identified in the
Need section of the application, and should include high-risk communities that are
subgrantees of cooperative agreement funds awarded under this announcement as well as
high-risk communities that are not direct subrecipients of these cooperative agreement funds.
Applicant work plans should be consistent with the logic model presented in this FOA.
Applicants are encouraged to look at the CDC Lead Poisoning Prevention Surveillance Logic
Model and the CDC HHLPPS Surveillance Evaluation and Performance Management Strategy
posted at www.cdc.gov/nceh/lead for additional information.
Each work plan should include the following in matrix format:
•
goals—these should be aligned with the outcomes in the logic model and narrative,
•
objectives—these should be related to the goals and also aligned with the outcomes in
the logic model,
•
activities planned to achieve objectives—these should be consistent with the outputs
and activities in the logic model related to the relevant outcomes
Page 17
•
a timeline to assess progress or completion,
•
named person(s) responsible for activities, and
•
description of data to assess activities (process indicators) and overall measures of
effectiveness (impact/outcome).
Applicants should specify process/implementation measures for the activities and measures of
effectiveness for the outcomes. Measures must be quantifiable and should be consistent with the
measures already listed in the evaluation and performance measurement strategy.
e. CDC Monitoring and Accountability Approach:
This FOA requires substantial involvement by CDC. Monitoring activities include frequent and
ongoing communication between CDC and awardees, site visits, and awardee reporting
(including work plans, performance, and financial reporting).
Monitoring may also include the following activities:
Ensuring that work plans are feasible based on the budget and consistent with the intent of the
award.
Ensuring that awardees are performing at a sufficient level to achieve objectives within stated
timeframes.
Working with awardees on adjusting the work plan based on achievement of objectives and
changing budgets.
Monitoring performance measures (both programmatic and financial) to assure satisfactory
performance levels.
Other activities deemed necessary to monitor the award, if applicable.
f. CDC Program Support to Awardees:
CDC activities are as follows:
Provide substantial technical assistance and oversight to newly hired staff as states and
large cities build or rebuild capacity for childhood lead poisoning surveillance.
Provide consultation and technical assistance in the form of recommendations
associated with techniques and approaches used to deliver or render services. Support
will be provided to the awardees in the development/enhancement and
implementation of their lead poisoning surveillance programs.
Review the use of data and information collection methods and analysis instruments
Page 18
specific to the use of CDC HHLPSS.
Provide assistance in implementing activities and identifying major program issues,
effective strategies, and priorities related to the cooperative agreement.
Assist awardees in assessing program effectiveness through the provision of technical
assistance in interpreting program evaluation indicators and evaluation measures.
Foster collaboration with other federal, state, and local health; environmental; and
housing agencies by initiating contacts, conference calls, and on-site visits to discuss
programmatic issues.
Provide HHLPSS at no cost, support awardees in deployment of the system and
migration of data from other systems to HHLPPS, and provide ongoing maintenance of
the system. (Note: Many states previously established HHLPSS under CDC-funded
cooperative agreements.)
Provide ongoing support for the deployment of HHLPPS and migration of legacy data to the
new system.
Provide assistance for the evaluation of surveillance activities and reporting and
disseminating reports to partners.
Provide consultation and technical assistance in the form of recommendations
associated with techniques and approaches used to deliver or render services.
Review the use of data and information collected to support development or
enhancement and implementation of population-based interventions and/or
designating areas as lead-safe.
Provide assistance in implementing activities and identifying major issues, effective
strategies, and priorities related to population-based interventions.
Page 19
B. Award Information
1. Type of Award: New (Type 1)
2. Award Mechanism: Cooperative Agreements
3. Fiscal Year: 2014
4. Approximate Total Fiscal Year Funding: $11,000,000
5. Approximate Total Project Period Funding: $33,000,000
6. Total Project Period Length: 3 (three) years
7. Approximate Number of Awards: Up to 41
8. Approximate Average Award: $250,000
9. Floor of Individual Award Range: None
10. Ceiling of Individual Award Range: $500,000 (If the request is over $500,000, the
application will be considered nonresponsive.)
11. Anticipated Award Date: September 1, 2014
12. Budget Period Length: 12 months, approved deviation to AGAM/CPAM requirements is
required.
Throughout the project period, CDC will continue the award based on availability of
funds, evidence of satisfactory progress by the awardee (as documented in required
reports), and the determination that continued funding is in the best interest of the
federal government. The total number of years for which federal support has been
approved (project period) will be shown in the “Notice of Award.” This information does
not constitute a commitment by the federal government to fund the entire period. The
total project period comprises the initial competitive segment and any subsequent
noncompetitive continuation award(s).
13. Direct Assistance:
Direct Assistance (DA) is not available through this FOA.
Page 20
C. Eligibility Information
1. Eligible Applicants:
Government Organizations:
State or their bona fide agents (includes the District of Columbia)
Large cities or their bona fide agents
2. Special Eligibility Requirements: N/A
3. Justification for Less than Maximum Competition:
This FOA is limited to State Governments or their Bona Fide Agents and Local
Governments or their Bona Fide Agents. Large cities must have a valid limit population
size of at least 750,000 using 2010 U.S. Census data or a 2011-2013 U.S. Census data
update. To appropriately follow-up on cases of lead poisoning and proactively prevent
additional cases, awardees must have the authority in their jurisdiction to address casemanagement activities that may involve Medicaid, housing, environmental regulation,
or consumer protection agencies. Awardees must be able to assure that follow-up care
is provided for children identified with elevated blood lead levels and that elimination or
control of lead hazards occurs within their jurisdictions. State and local governments
are the only entities with these required authorities to achieve the mission of the FOA.
The FOA requires applicants to demonstrate the burden of lead poisoning in their
jurisdictions and the current request would allow for focusing of limited resources to
states and local entities that have the greatest ability to address the housing,
environmental, consumer and health care factors that contribute to childhood lead
poisoning.
4. Cost Sharing or Matching:
Cost sharing or matching funds are not required for this program. Although no statutory
matching requirement for this FOA exists, leveraging other resources and related
ongoing efforts to promote sustainability is strongly encouraged.
5. Maintenance of Effort:
Maintenance of effort is not required for this program.
Page 21
D. Application and Submission Information
Additional materials that may be helpful to applicants:
www.cdc.gov/od/pgo/funding/docs/FinancialReferenceGuide.pdf.
1. Required Registrations: An organization must be registered at the three following locations
before it can submit an application for funding at www.grants.gov.
a. Data Universal Numbering System: All applicant organizations must obtain a Data
Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit
identification number provided by Dun & Bradstreet (D&B). It will be used as the
universal identifier when applying for federal awards or cooperative agreements.
The applicant organization may request a DUNS number by telephone at 1-866-7055711 (toll free) or on the Internet at
http://fedgov.dnb.com/webform/displayHomePage.do. The DUNS number will be
provided at no charge.
If funds are awarded to an applicant organization that includes sub-awardees, those
sub-awardees must provide their DUNS numbers before accepting any funds.
b. System for Award Management (SAM): The SAM is the primary registrant database
for the federal government and the repository into which an entity must submit
information required to conduct business as an awardee. All applicant organizations
must register with SAM, then they will be assigned a SAM number. All information
relevant to the SAM number must be current at all times during which the applicant
has an application under consideration for funding by CDC. If an award is made, the
SAM information must be maintained until a final financial report is submitted or
the final payment is received, whichever is later. The SAM registration process
usually requires not more than five business days, and registration must be renewed
annually. Additional information about registration procedures may be found at
www.SAM.gov.
c. Grants.gov: The first step in submitting an application online is registering your
organization at www.grants.gov, the official E-grant website of the U.S. Department
of Health and Human Services. Registration information is located on the “Register”
link at www.grants.gov.
All applicant organizations must register at www.grants.gov. The one-time
registration process usually takes no more than five days to complete. Applicants
must start the registration process as early as possible.
2. Request Application Package: Applicants may access the application package at
Page 22
www.grants.gov.
3. Application Package: Applicants must download the SF-424 package (Application for
Federal Assistance) associated with this funding opportunity at www.grants.gov. If Internet
access is not available, or if the online forms cannot be accessed, applicants may call the
CDC PGO staff at 770-488-2700 or e-mail PGO at [email protected] for assistance. CDC
Telecommunications for persons with hearing loss is available at TTY 1-888-232-6348.
4. Submission Dates and Times: If the application is not submitted by the deadline published
in the FOA, it will not be processed. PGO personnel will notify the applicant that their
application did not meet the deadline. The applicant must receive preapproval to submit a
paper application (see the Other Submission Requirements section for additional details). If
the applicant is authorized to submit a paper application, it must be received by the
deadline provided by PGO.
a. Letter of Intent (LOI) Deadline (must be emailed or postmarked by): June 30, 2014
b. Application Deadline: July 22, 2014, 11:59 p.m. U.S. Eastern Standard Time, at
www.grants.gov
5. CDC Assurances and Certifications: All applicants are required to sign and submit the
“Assurances and Certifications” documents as indicated at
www.cdc.gov/od/pgo/funding/grants/foamain.shtm.
Applicants may follow either of the following processes:
•
Complete the applicable assurances and certifications, name the file “Assurances
and Certifications” and upload it as a PDF file at www.grants.gov.
Complete the applicable assurances and certifications and submit them directly to
CDC on an annual basis at http://wwwn.cdc.gov/grantsassurances/Homepage.aspx.
Assurances and certifications submitted directly to CDC will be kept on file for one year and
will apply to all applications submitted to CDC within one year of the submission date.
6. Content and Form of Application Submission: Applicants are required to include all of the
following documents with their application package at www.grants.gov.
7. Letter of Intent (LOI):
Descriptive title of proposed project:
Name, address, telephone number, and email address of the Principal
Investigator/Project Director
Name, address, telephone number, and email address of the primary contact for
Page 23
writing and submitting this application
Number and title of this funding opportunity
The LOI must be received via email to
Kimball F. Credle
Project Officer
Division of Emergency and Environmental Health Services
National Center for Environmental Health, CDC
Email: [email protected]
Office phone: (770) 488-3643
8. Table of Contents: (No page limit and not included in Project Narrative limit)
Provide a detailed table of contents for the entire submission package that includes all of
the documents in the application and headings in the Project Narrative section. Name the
file “Table of Contents” and upload it as a PDF file under “Other Attachment Forms” at
www.grants.gov.
9. Project Abstract Summary: (Maximum 1 page)
A project abstract is included on the mandatory documents list and must be submitted at
www.grants.gov. The project abstract must be a self-contained, brief summary of the
proposed project including the purpose and outcomes. This summary must not include any
proprietary or confidential information. Applicants must enter the summary in the “Project
Abstract Summary” text box at www.grants.gov.
10. Project Narrative: Maximum of 30 pages, single spaced, Calibri 12 point, 1-inch margins,
number all pages. Content beyond 30 pages will not be considered. The 30-page limit
includes the work plan.
The Project Narrative must include all of the bolded headings shown in this section. The
Project Narrative must be succinct and self-explanatory and must be in the order outlined in
this section. It must address outcomes and activities to be conducted over the entire
project period as identified in the CDC Project Description section.
Applicants must submit a Project Narrative with the application forms. Applicants must
name this file “Project Narrative” and upload it at www.grants.gov.
a. Background: Applicants must provide a description of relevant background
information that includes the context of the problem. (See CDC Background.)
b. Approach
i. Problem Statement: Applicants must describe the core information relative to
Page 24
the problem for the jurisdictions or populations they serve. Specifically,
applicants must demonstrate significantly high burden of lead poisoning in
their jurisdiction’s based on the number and percent children tested with high
BLLs and/or conditions that contribute to high BLLs within the populations
served. The core information must help reviewers understand how the
applicant’s response to the FOA will address the public health problem and
support public health priorities. (See CDC Project Description.)
ii. Purpose: Applicants must describe in 2-3 sentences specifically how their
application will address the problem as described in the CDC Project
Description.
iii. Outcomes: Applicants must clearly identify the outcomes they expect to
achieve by the end of the project period. Outcomes are the results that the
program intends to achieve. All outcomes must indicate the intended direction
of change (i.e., increase, decrease, maintain). (See the program logic model in
the Approach section of the CDC Project Description.)
iv. Strategy and Activities: Applicants must provide a clear and concise
description of the strategies and activities they will use to achieve the project
period outcomes. Whenever possible, applicants should use evidence-based
program strategies as identified by the Guide to Community Preventive
Services1 (or similar reviews) and explicitly reference the source. Applicants
may propose additional strategies and activities to achieve the outcomes.
Applicants must select existing evidence-based strategies that meet their
needs or describe the rationale for developing and evaluating new strategies
or practice-based innovations. (See the Strategies and Activities section of the
CDC Project Description.)
1. Collaborations: Applicants must describe how they will collaborate with
programs and organizations either internal or external to CDC.
Applicants must provide any existing MOUs/MOAs and name the file
“MOUs/MOAs” and upload them as pdf files on www.grants.gov.
2. Target Populations: Refer to the CDC Project Description (Approach:
Target Population section). Applicants must describe the specific target
population(s) to be addressed in their jurisdictions to allocate limited
resources, target those at greatest health risk, and achieve the greatest
1
www.thecommunityguide.org/index.html
Page 25
health impact. Applicants should use data, including social determinants
data, to identify communities within their jurisdictions or communities
served that are disproportionately affected by the public health problem,
and applicants should plan activities to reduce or eliminate these
disparities. Disparities by race, ethnicity, gender identity, sexual
orientation, geography, socioeconomic status, disability status, primary
language, health literacy, and other relevant dimensions (e.g., tribal
communities) should be considered.
Inclusion: Applicants should address how they will be inclusive of specific
populations that can benefit from programmatic strategies. These
populations include groups such as people with disabilities; non-Englishspeaking populations; lesbian, gay, bisexual, and transgender (LGBT)
populations; appropriate age groups; or other populations that may
otherwise be missed by the program. Refer to the CDC Project
Description (Approach: Inclusion section), if applicable.
c. Applicant Evaluation and Performance Measurement Plan: Applicants must
provide an overall jurisdiction-specific or community-specific evaluation and
performance measurement plan that is consistent with the CDC Evaluation and
Performance Measurement Strategy section of the CDC Project Description of this
FOA. Data collected must be used for ongoing monitoring of the award to evaluate
its effectiveness and for continuous program improvement.
The plan must describe the following:
How key program partners will be engaged in the evaluation and
performance measurement planning processes.
The type of evaluations to be conducted (i.e., process and/or outcome).
Key evaluation questions to be answered.
Other information that must be included, as determined by the CDC program
(e.g., performance measures to be developed by the applicant).
Potentially available data sources and feasibility of collecting appropriate
evaluation and performance data.
How evaluation findings will be used for continuous program and quality
improvement.
How evaluation and performance measurement will contribute to
development of the evidence base (in cases where program strategies are
Page 26
being used that lack a strong evidence base of effectiveness).
Evaluation and performance measurement help demonstrate achievement of
program outcomes; build a stronger evidence base for specific program
interventions; clarify applicability of the evidence base to different populations,
settings, and contexts; and drive continuous program improvement. Evaluation and
performance measurement also can determine if program strategies are scalable
and effective at reaching target populations.
Applicants must provide an overall jurisdiction-/community-specific evaluation and
performance measurement plan that are consistent with the CDC evaluation and
performance measurement strategy.
If awarded, funded applicants must provide a more-detailed plan within the first six
months of programmatic funding. This more-detailed evaluation and performance
measurement plan should be developed by awardees with support from CDC as part
of first-year project activities. This more-detailed evaluation plan will build on the
elements stated in the initial plan. The detailed plan should be no more than 35
pages. At a minimum, and in addition to the elements of the initial plan, it must
describe
How often evaluation and performance data are to be collected.
How data will be reported.
How evaluation findings will be used for continuous quality and program
improvement.
How evaluation and performance measurement will yield findings to
demonstrate the value of the FOA (e.g., impact on improving public health
outcomes, effectiveness of FOA, cost-effectiveness or cost benefit).
Dissemination channels and audiences (including public dissemination).
Other information requested, as determined by the CDC program
When developing evaluation and performance measurement plans, applicants are
encouraged to use the CDC Framework for Program Evaluation in Public Health
(CDC. Framework for program evaluation in public health. MMWR. 1999;48[RR-11];
www.cdc.gov/eval).
d. Organizational Capacity of Applicants to Implement the Approach: Applicant must
address the organizational capacity requirements as described in the CDC Project
Description. Applicants must name this file “CVs/Resumes” or “Organizational
Page 27
Charts” and upload it at www.grants.gov.
The organizational capacity statement may describe how the applicant agency (or
the particular division of a larger agency with responsibility for this project) is
organized, the nature and scope of its work, and/or the capabilities it possesses.
Applicants may include a detailed description of the entity’s experience, program
management components, the entity’s readiness to establish contracts in a timely
manner, and a plan for long-term sustainability of the project, if applicable.
Applicants may describe how they will assess staff competencies and develop a plan
to address gaps through organizational and individual training and development
opportunities.
Applicants may describe how they are reimbursed for case management/home
visiting and environmental inspections and enforcement. If they do not receive
reimbursement for these services by Medicaid and other health insurance,
applicants must describe how they will ensure that these services will be reimbursed
by the end of the first budget period.
Also, applicants may describe their current status in applying for public health
department accreditation or evidence of accreditation. Information on accreditation
may be found at www.phaboard.org.
Applicants shall describe how elevated blood lead data will be provided quarterly to
housing authorities of federally subsidized housing, as required under HUD 1012
Lead-Safe Housing Rule 24 CFR 35.1225 (www.gpoaccess.gov/cfr/retrieve.html).
Guidance for sharing data with partners/collaborators is provided under the Health
Insurance Portability and Accountability Act (HIPAA) permitted uses and disclosures:
A covered entity is permitted, but not required, to use and disclose protected
health information, without an individual’s authorization, for the following
purposes or situations:
to the individual (unless required for access or accounting of disclosures);
treatment, payment, and health care operations;
opportunity to agree or object;
incident to an otherwise permitted use and disclosure;
public interest and benefit activities; and
limited data set for the purposes of research, public health or health care
operations.
Page 28
Covered entities may rely on professional ethics and best judgments in deciding
which of these permissive uses and disclosures to make.
11. Work Plan: (Included in the Project Narrative’s 30 page limit)
Applicants must prepare a work plan consistent with the Work Plan section of the CDC
Project Description. The work plan integrates and delineates more specifically how the
awardee plans to carry out achieving the project period outcomes/objectives, strategies
and activities, indicators, evaluation, and performance measurement, including key
milestones and person(s) responsible. CDC will provide feedback and technical assistance to
awardees to finalize the work plan post-award. The narrative of the work plan should follow
the CDC logic model.
Include a tentative work plan outline for Phase 2 (years two and three) of the project period
with the application as an appendix. The tentative work plan should include goals,
objectives, activities, and a timetable for the remaining years of the proposed project for
each element. The outline should follow the CDC logic model.
Applicants must name this file “Work Plan” and upload it as a PDF file on www.grants.gov.
12. Budget Narrative:
Applicants must submit an itemized budget narrative, which may be scored as part of the
Organizational Capacity of Awardees to Execute the Approach section. When developing
the budget narrative, applicants must consider whether the proposed budget is reasonable
and consistent with the purpose, outcomes, and program strategy outlined in the project
narrative. The budget must include the following:
Salaries and wages
Fringe benefits
Consultant costs
Equipment
Supplies
Travel
Other categories
Total direct costs
Total indirect costs
Contractual costs
Page 29
For guidance on completing a detailed budget, see the Budget Preparation Guidelines at
www.cdc.gov/od/pgo/funding/grants/foamain.shtm.
If applicable and consistent with statutory authority, applicant entities may use funds for
activities as they relate to the intent of this FOA to meet national standards. Applicant
entities include state, and local, and territorial governments or their bona fide agents;
political subdivisions of states (in consultation with states).
Activities include those that enable a public health organization to deliver public health
services (for example, activities that ensure a capable and qualified workforce, up-to-date
information systems, and the capability to assess and respond to public health needs). Use
of these funds must focus on achieving a minimum of one national standard that supports
the intent of the FOA. Proposed activities must be included in the budget narrative and
must indicate which standards will be addressed.
Applicants must name this file “Budget Narrative” and upload it as a PDF file at
www.grants.gov. If requesting indirect costs in the budget, a copy of the indirect cost-rate
agreement is required. If the indirect cost rate is a provisional rate, the agreement must
have been made less than 12 months earlier. Applicants must name this file “Indirect Cost
Rate” and upload it at www.grants.gov.
13. Special Eligibility Requirements: N/A
14. Tobacco and Nutrition Policies: N/A
15. Health Insurance Marketplaces:
A healthier country is one in which Americans are able to access the care they need to
prevent the onset of disease and manage disease when it is present. The Affordable Care
Act, the health care law of 2010, creates new Health Insurance Marketplaces, also known as
Exchanges, to offer millions of Americans affordable health insurance coverage. In addition,
the law helps make prevention affordable and accessible for Americans by requiring health
plans to cover certain recommended preventive services without cost sharing. Outreach
efforts will help families and communities understand these new options and provide
eligible individuals the assistance they need to secure and retain coverage as smoothly as
possible. For more information on the Marketplaces and the health care law, visit
www.HealthCare.gov.
16. Intergovernmental Review:
Page 30
The application is subject to Intergovernmental Review of Federal Programs, as governed by
Executive Order 12372, which established a system for state and local intergovernmental
review of proposed federal assistance applications. Applicants should inform their state
single point of contact (SPOC) as early as possible that they are applying prospectively for
federal assistance and request instructions on the state’s process. The current SPOC list is
available at www.whitehouse.gov/omb/grants_spoc/.]
17. Funding Restrictions:
The following restrictions must be considered while planning the programs and writing the
budget:
Awardees may not use funds for research.
Awardees may not use funds for clinical care.
Awardees may use funds only for reasonable program purposes, including
personnel, travel, supplies, and services.
Generally, awardees may not use funds to purchase furniture or equipment. Any
such proposed spending must be clearly identified in the budget.
Reimbursement of preaward costs is not allowed.
Other than for normal and recognized executive-legislative relationships, no funds
may be used
o for publicity or propaganda purposes; for the preparation, distribution, or
use of any material designed to support or defeat the enactment of
legislation before any legislative body or
o for the salary or expenses of any grant or contract recipient, or an agent
acting for such recipient, related to any activity designed to influence the
enactment of legislation, appropriations, regulation, administrative action, or
executive order proposed or pending before any legislative body.
o [See Additional Requirement (AR) 12 for detailed guidance on this
prohibition and additional guidance on lobbying for CDC awardees.]
The direct and primary recipient in a cooperative agreement program must perform
a substantial role in carrying out project outcomes and not merely serve as a conduit
for an award to another party or provider who is ineligible.
Awardees must comply with federal restrictions on food purchases. Data collection
initiated under this cooperative agreement has been approved by the Office of
Management and Budget under OMB Number (0920-0931), “Healthy Homes and
Page 31
Lead Poisoning Surveillance System (HHLPSS).” Expiration Date April 30, 2015. Any
changes to the existing data collection will be subject to review and approval by the
office of Management and Budget (OMB) under the Paperwork Reduction Act. In
addition, applicants must demonstrate that its lead surveillance reporting system is
or will qualify it for the exception accorded under 5 CFR§1320.3(b)(3) –that is that
such data are already collected by state, local or tribal governments in the absence
of a federal requirement.
18. Other Submission Requirements:
a. Electronic Submission: Applications must be submitted electronically at
www.grants.gov. The application package can be downloaded at www.grants.gov.
Applicants can complete the application package off-line and submit the application by
uploading it at www.grants.gov. All application attachments must be submitted using a
PDF file format. Directions for creating PDF files can be found at www.grants.gov. File
formats other than PDF may not be readable by PGO Technical Information
Management Section (TIMS) staff.
Applications must be submitted electronically by using the forms and instructions
posted for this funding opportunity at www.grants.gov.
If Internet access is not available or if the forms cannot be accessed online, applicants
may contact the PGO TIMS staff at 770-488-2700 or by e-mail at [email protected],
Monday through Friday, 7:30 a.m.–4:30 p.m., except federal holidays. Electronic
applications will be considered successful if they are available to PGO TIMS staff for
processing from www.grants.gov on the deadline date.
b. Tracking Number: Applications submitted through www.grants.gov are electronically
time and date-stamped and assigned a tracking number. The applicant’s Authorized
Organization Representative (AOR) will be sent an e-mail notice of receipt when
www.grants.gov receives the application. The tracking number documents that the
application has been submitted and initiates the required electronic validation process
before the application is made available to CDC.
c. Validation Process: The application submission is not concluded until the validation
process is completed successfully. After the application package is submitted, the
applicant will receive a submission receipt e-mail generated by www.grants.gov. A
second e-mail message to applicants will then be generated by www.grants.gov that will
either validate or reject the submitted application package. This validation process may
take as long as two business days. Applicants are strongly encouraged to check the
status of their application to ensure that submission of their package has been
Page 32
completed and no submission errors have occurred. Applicants also are strongly
encouraged to allocate ample time for filing to guarantee that their application can be
submitted and validated by the deadline published in the FOA. Non-validated
applications will not be accepted after the published application deadline date.
If you do not receive a validation e-mail within two business days of application
submission, please contact www.grants.gov. For instructions on how to track your
application, refer to the e-mail message generated at the time of application submission
or the Application User Guide, Version 3.0, page 57.
d. Technical Difficulties: If applicants have technical difficulties at www.grants.gov, they
should contact Customer Service at www.grants.gov. The www.grants.gov Contact
Center is available 24 hours a day, 7 days a week, except federal holidays. The Contact
Center is available by phone at 1-800-518-4726 or by e-mail at
[email protected]. Application submissions sent by e-mail or fax, or on CDs or
thumb drives, will not be accepted. Please note that www.grants.gov is managed by
HHS.
e. Paper Submission: If applicants have technical difficulties at www.grants.gov, they
should call the www.grants.gov Contact Center at 1-800-518-4726 or e-mail them at
[email protected] for assistance. After consulting with the Contact Center, if
the technical difficulties remain unresolved and electronic submission is not possible,
applicants may e-mail or call CDC GMO/GMS before the deadline and request
permission to submit a paper application. Such requests are handled on a case-by-case
basis.
An applicant’s request for permission to submit a paper application must
1. Include the www.grants.gov case number assigned to the inquiry;
2. Describe the difficulties that prevent electronic submission and the efforts taken
with the www.grants.gov Contact Center to submit electronically; and
3. Be postmarked at least three calendar days before the application deadline.
Paper applications submitted without prior approval will not be considered. If a
paper application is authorized, PGO will advise the applicant of specific
instructions for submitting the application (e.g., original and two hard copies of
the application by U.S. mail or express delivery service).
Page 33
E. Application Review Information
1. Review and Selection Process: Applications will be reviewed in three phases.
a. Phase I Review:
All applications will be reviewed initially for completeness by CDC PGO staff and will be
reviewed jointly for eligibility by CDC/NCEH and PGO. Incomplete applications and
applications that do not meet the eligibility criteria will not advance to Phase II review.
Applicants will be notified that their applications did not meet eligibility or published
submission requirements.
b. Phase II Review:
An objective review panel will evaluate complete, eligible applications in accordance
with the “Criteria” section of the FOA. Applicants will be notified electronically if their
applications did not meet eligibility and/or published submission requirements thirty
(30) days after the completion of Phase II review.
i.
Background and need (15 points):
a. Does the applicant demonstrate a significantly high burden of lead poisoning
and/or conditions that contribute to lead poisoning within the populations it
serves based on the number and percent of children with high BLLS? (10
points)?
b. Does the applicant justify the need for this program within its geographic
area and adequately describe sub-populations at greatest risk for lead
poisoning? (5 points)
ii.
Approach (55 points):
Surveillance (total 46 points)
a. Does the applicant adequately describe a surveillance system (new or
modified existing system) that will collect, compile, and track lead hazards?
Does the system allow for entry of people and addresses without a blood
lead test? Does the system allow for multiple laboratory tests and addresses
to be related to a single person over multiple years? (4 points)
b. Does the applicant describe data dissemination to CDC and partners? (4
points)
c. Does the applicant have data-sharing agreements in place with housing, code
enforcement, and other health agencies? (4 points)
Page 34
d. Does the applicant describe their ability to be reimbursed by Medicaid and
private insurance for case management/home visiting and environmental
inspections and enforcement or a plan to ensure these services are
reimbursed by the end of the first budget year? (4 points)
e. Does the applicant describe their ability to use surveillance data to target
appropriate population-based, primary prevention interventions in high risk
areas by collaborating with housing rehabilitation, housing and health code
enforcement, health care systems and early childhood and other educational
agencies? (30 points)
Work Plan (total 9 points)
a. Is the concept adequately developed, well-reasoned, and appropriate to the
aim of the project? Is the plan adequate to carry out the proposed objectives
for developing or enhancing and implementing the lead poisoning
surveillance program? (3 points)
b. Are the goals achievable based on the information provided? Have sound
objectives been included that are consistent with the activities described in
this announcement? (3 points)
c. Are the proposed timeline and schedule feasible? (SMART: specific,
measurable, applicable/appropriate, relevant, time-phased)? Do they include
a specific plan for the first year of the project and a tentative work plan for
years 2 and 3? (3 points)
ii.
Evaluation and Performance Management: (20 points)
a. Does the applicant provide a logic model that addresses the program as whole
and includes inputs, activities of staff and strategic partners, outputs, objectives,
and goals? (5 points)
b. Does the applicant describe a program evaluation plan that includes
i. process and outcome indicators? (4 points)
ii. data collection and analysis strategies? (1 points)
iii. approaches to use evaluation findings to improve the quality,
effectiveness, and efficiency of the program? (2 points)
iv. staff conducting evaluation? (1 points)
v. method of measuring the overall impact of the project in decreasing lead
Page 35
hazards and promoting the health of the high-risk population? (7 points)
iii. Applicant’s Organizational Capacity to Implement the Approach: (10 points)
a. Do existing (or planned) key personnel have the necessary skills, abilities, and
experiences to develop, implement carryout, and evaluate the project? (5
points)
b. Does the applicant describe existing (or planned) staff roles in the development,
implementation, and evaluation of the project, their specific responsibilities, and
their level of effort and time commitment? (5 points)
Not more than thirty days after the Phase II review is completed, applicants will be
notified electronically if their application does not meet eligibility or published
submission requirements.
c. Phase III Review:
Applications will be funded in order by score and rank determined by the review panel.
In addition, the demonstrated burden of lead poisoning in the applicant’s jurisdiction
may affect the funding decision.
2. Announcement and Anticipated Award Dates:
Anticipated Award Date: September 1, 2014
F. Award Administration Information
1. Award Notices:
Awardees will receive an electronic copy of the Notice of Award (NoA) from CDC PGO. The
NoA shall be the only binding, authorizing document between the awardee and CDC. The
NoA will be signed by an authorized GMO and e-mailed to the awardee program director.
Any applicant awarded funds in response to this FOA will be subject to the DUNS, SAM
Registration, and Federal Funding Accountability And Transparency Act Of 2006 (FFATA)
requirements.
Unsuccessful applicants will receive notification of these results by e-mail with delivery
receipt or by U.S. mail.
2. Administrative and National Policy Requirements:
Awardees must comply with the administrative requirements outlined in 45 C.F.R. Part 74
or Part 92, as appropriate. Brief descriptions of relevant provisions are available at
Page 36
www.cdc.gov/od/pgo/funding/grants/additional_req.shtm.
The following Administrative Requirements (AR) apply to this project:
List applicable ARs – Determine which of the ARs apply and DELETE any that do not apply.
[Generally applicable ARs:
AR-7: Executive Order 12372
AR-9: Paperwork Reduction Act
AR-10: Smoke-Free Workplace
AR-11: Healthy People 2020
AR-12: Lobbying Restrictions
AR-13: Prohibition on Use of CDC Funds for Certain Gun Control Activities
AR-24: Health Insurance Portability and Accountability Act
AR-25: Release and Sharing of Data
AR-26: National Historic Preservation Act of 1966
AR-29: Compliance with Executive Order 13513 (Federal Leadership on Reducing
Text Messaging while Driving, October 1, 2009)
AR-30: Compliance with Section 508 of the Rehabilitation Act of 1973
AR-33: Plain Writing Act of 2010
AR-34: Patient Protection and Affordable Care Act (e.g., a tobacco-free campus
policy and a lactation policy consistent with S4207)
For more information on the C.F.R., visit the National Archives and Records Administration
at www.access.gpo.gov/nara/cfr/cfr-table-search.html.
3. Reporting
a. CDC Reporting Requirements:
Reporting provides continuous program monitoring and identifies successes and
challenges that awardees encounter throughout the project period. Also, reporting is a
requirement for awardees who want to apply for yearly continuation of funding.
Reporting helps CDC and awardees because it
Helps target support to awardees, particularly for cooperative agreements;
Provides CDC with periodic data to monitor awardee progress toward meeting the
FOA outcomes and overall performance goals;
Allows CDC to track performance measures and evaluation findings to validate
continuous program improvement throughout the project period and to determine
applicability of evidence-based approaches to different populations, settings, and
Page 37
contexts; and
Enables CDC to assess the overall effectiveness and influence of the FOA.
As described in the following text, awardees must submit an annual performance
report, ongoing performance measures data, administrative reports, and a final
performance and financial report. A detailed explanation of any additional reporting
requirements will be provided in the Notice of Award to successful applicants.
b. Specific reporting requirements:
i. Awardee Evaluation and Performance Measurement Plan: Awardees must provide
a more-detailed evaluation and performance measurement plan within the first six
months of the project. This more detailed plan must be developed by awardees as
part of first-year project activities, with support from CDC. This more-detailed plan
must build on the elements stated in the initial plan and must be no more than 25
pages. At a minimum, and in addition to the elements of the initial plan, this plan
must
Indicate how often evaluation and performance data are to be collected.
Describe how data will be reported.
Describe how evaluation findings will be used to ensure continuous quality
and program improvement.
Describe how evaluation and performance measurement will yield findings
that will demonstrate the value of the FOA (e.g., effect on improving public
health outcomes; effectiveness of the FOA as it pertains to performance
measurement, cost-effectiveness, or cost-benefit).
Describe dissemination channels and audiences (including public
dissemination).
Describe other information requested and as determined by the CDC
program.
When developing evaluation and performance measurement plans, applicants are
encouraged to use the Introduction to Program Evaluation for Public Health
Programs: A Self-Study Guide (available at www.cdc.gov/eval/guide/index.htm).
ii. Annual Performance Report: This report must not exceed 45 pages excluding
administrative reporting; attachments are not allowed but weblinks are allowed.
The awardee must submit the Annual Performance Report via www.grants.gov 120
days before the end of the budget period. In addition, the awardee must submit an
Page 38
annual Federal Financial Report within 90 days after the end of the calendar quarter
in which the budget year ends.
The Annual Performance Report must include the following:
Performance Measures (including outcomes)–Awardees must report on
performance measures for each budget period and update measures, if
needed.
Evaluation Results–Awardees must report evaluation results for the work
completed to date (including any data about the effects of the program).
Work Plan –Awardees must update the work plan each budget period.
Successes
o Awardees must report progress on completing activities outlined in the
work plan.
o Awardees must describe any additional successes (e.g., identified through
evaluation results or lessons learned) achieved in the past year.
o Awardees must describe success stories.
Challenges
o Awardees must describe any challenges that might affect their ability to
achieve annual and project-period outcomes, conduct performance
measures, or complete the activities in the work plan.
o Awardees must describe any additional challenges (e.g., identified
through evaluation results or lessons learned) encountered in the past
year.
CDC Program Support to Awardees
o Awardees must describe how CDC could help them overcome challenges
to achieving annual and project-period outcomes and performance
measures and completing activities outlined in the work plan.
Administrative Reporting (No page limit)
o SF-424A Budget Information–Non-Construction Programs.
o Budget Narrative–must use the format outlined in the Content and Form
of Application Submission, Budget Narrative section of this FOA___?.
o Indirect Cost-Rate Agreement.
Page 39
This report must not exceed 35 pages excluding the work plan and administrative
reporting.
Any carryover request must
Express a bona fide need for permission to use an unobligated balance;
Include a signed, dated, and accurate Federal Financial Report (FFR) for the
budget period from which funds will be transferred (as much as 75% of
unobligated balances); and
Include a list of proposed activities, an itemized budget, and a narrative
justification for those activities.
The awardee must submit the Annual Performance Report via www.grants.gov 120
days before the end of the budget period.
iii. Performance Measure Reporting: CDC programs must require awardees to submit
performance measures at least annually and may require reporting more frequently.
Performance measure reporting must be limited to data collection. When funding is
awarded initially, CDC programs must specify the required reporting frequency, data
fields, and format.
iv. Federal Financial Reporting (FFR): The annual FFR form (SF-425) is required and
must be submitted through eRA Commons2 within 90 days after each budget period
ends. The report must include only those funds authorized and disbursed during the
timeframe covered by the report. The final report must indicate the exact balance of
unobligated funds and may not reflect any unliquidated obligations. The final FFR
expenditure data and the Payment Management System’s (PMS) cash transaction
data must correspond; no discrepancies between the data sets are permitted.
Failure to submit the required information by the due date may affect adversely
future funding of the project. If the information cannot be provided by the due date,
awardees are required to submit a letter of explanation and include the date by
which the information will be provided.
v. Final Performance and Financial Report: At the end of the project period, awardees
must submit a final report including a final financial and performance report. This
report is due 90 days after the project period ends. (CDC must include a page limit
for the report, with a maximum of 40 pages).
At a minimum, this report must include
2
https://commons.era.nih.gov/commons/
Page 40
Performance Measures (including outcomes)–Awardees must report final
performance data for all performance measures for the project period.
Evaluation Results–Awardees must report final evaluation results for the
project period.
Impact/ Results–Awardees must describe the effects or results of the work
completed over the project period, including success stories.
Additional forms as described in the Notice of Award, including Equipment
Inventory Report and Final Invention Statement.
FFR (SF-425).
Awardees must email the report to the CDC Project Officer and the Grants
Management Specialist listed in the Agency Contacts section of this FOA.
General Provisions Title II
Section 203 - Cap on Researcher Salaries
None of the funds appropriated in this title shall be used to pay the salary of an
individual, through a grant or other extramural mechanism, at a rate in excess of
Executive Level II; reduced from $199,700 to $179,700 effective December 23, 2011.
Section 217 - Gun Control Prohibition
None of the funds made available in this title may be used, in whole or in part, to
advocate or promote gun control.
Section 220 - Prevention Fund Reporting Requirements
Prevention Fund Reporting Requirements: This award requires the grantee to
complete projects or activities which are funded under the Prevention and Public
Health Fund (PPHF) (Section 4002 of Public Law 111-148) to report on use of PPHF
funds provided through this award. Information from these reports will be made
available to the public.
Grantees awarded a grant, cooperative agreement, or contract from such funds with
a value of $25,000 or more shall produce reports on a semi-annual basis with a
reporting cycle of January 1 - June 30 and July 1 - December 31; and email such
reports to the CDC website (template and point of contact to be provided after
award) no later than 20 calendar days after the end of each reporting period (i.e.
July 20 and January 20, respectively). Grantee reports must reference the NoA
number and title of the grant, and include a summary of the activities undertaken
and identify any sub-awards (including the purpose of the award and the identity of
Page 41
each sub-recipient).
Responsibilities for Informing Sub-recipients: Grantees agree to separately identify
each sub-recipient, document the execution date sub-award, date(s) of the
disbursement of funds, the Federal award number, any special CFDA number
assigned for PPHF fund purposes, and the amount of PPHF funds. When a grantee
awards PPHF funds for an existing program, the information furnished to subrecipients shall distinguish the sub-awards of incremental PPHF funds from regular
sub-awards under the existing program.
General Provisions, Title V
Section 503 - Proper Use of Appropriations - Publicity and Propaganda [LOBBYING]
FY2012 Enacted
(a) No part of any appropriation contained in this Act or transferred pursuant to
section 4002 of Public Law 111-148 shall be used, other than for normal and
recognized executive-legislative relationships, for publicity or propaganda purposes,
for the preparation, distribution, or use of any kit, pamphlet, booklet, publication,
electronic communication, radio, television, or video presentation designed to
support or defeat the enactment of legislation before the Congress or any State or
local legislature or legislative body, except in presentation of the Congress or any
State or local legislature itself, or designed to support or defeat any proposed or
pending regulation, administrative action, or order issued by the executive branch of
any State or local government itself.
(b) No part of any appropriate contained in this Act or transferred pursuant to
section 4002 of Public Law 111-148 shall be used to pay the salary or expenses of
any grant or contract recipient, or agent acting for such recipient, related to any
activity designed to influence the enactment of legislation, appropriations,
regulation, administrative action, or Executive order proposed or pending before the
Congress or any State government, State legislature or local legislature or legislative
body, other than normal and recognized executive legislative relationships or
participation by an agency or officer of an State, local or tribal government in
policymaking and administrative processes within the executive branch of that
government.
Page 42
(c) The prohibitions in subsections (a) and (b) shall include any activity to advocate
or promote any proposed, pending, or future Federal, State or local tax increase, or
any proposed, pending, or future requirement or restriction on any legal consumer
product, including its sale of marketing, including but not limited to the advocacy or
promotion of gun control.
Section 253 - Needle Exchange
Notwithstanding any other provision of this Act, no funds appropriated in this Act
shall be used to carry out any program of distributing sterile needles or syringes for
the hypodermic injection of any illegal drug.
General Provisions, Title IV
Section 738 - Funding Prohibition - Restricts dealings with corporations with recent
felonies
None of the funds made available by this Act may be used to enter into a contract,
memorandum of understanding, or cooperative agreement with, make a grant to, or
provide a loan or loan guarantee to any corporation that was convicted (or had an
officer or agent of such corporation acting on behalf of the corporation convicted) of
a felony criminal violation under any Federal or State law within the preceding 24
months, where the awarding agency is aware of the conviction, unless the agency
has considered suspension or debarment of the corporation, or such officer or
agent, and made a determination that this further action is not necessary to protect
the interests of the Government.
Section 739 - Limitation Re: Delinquent Tax Debts - Restricts dealings with
corporations with unpaid federal tax liability
None of the funds made available by this act may be used to enter into a contract,
memorandum of understanding, or cooperative agreement with, make a grant to, or
provide a loan or loan guarantee to, any corporation that any unpaid Federal tax
liability that has been assessed, for which all judicial and administrative remedies
have been exhausted or have lapsed, and that is not being paid in a timely manner
pursuant to an agreement with the authority responsible for collecting the tax
liability, where the awarding agency is aware of the unpaid tax liability, unless the
agency has considered suspension or debarment of the corporation and made a
determination that this further action is not necessary to protect the interests of the
Government.
Section 433 - Funding Prohibition - Restricts dealings with corporations with recent
Page 43
felonies
None of the funds made available by this Act may be used to enter into a contract,
memorandum of understanding, or cooperative agreement with, make a grant to, or
provide a loan or loan guarantee to, any corporation that was convicted (or had an
officer or agent of such corporation acting on behalf of the corporation convicted) of
a felony criminal violation under any Federal law within the preceding 24 months,
where the awarding agency is aware of the conviction, unless the agency has
considered suspension or debarment of the corporation, or such officer or agent and
made a determination that further action is not necessary to protect the interests of
the Government.
Section 434 - Limitation Re: Delinquent Tax Debts - Restricts dealings with
corporations with unpaid federal tax liability
None of the funds made available by this Act may be used to enter into a contract,
memorandum of understanding, or cooperative agreement with, make a grant to, or
provide a loan or loan guarantee to, any corporation with respect to which any
unpaid Federal tax liability that has been assessed, for which all judicial and
administrative remedies have been exhausted or have lapsed, and that is not being
paid in a timely manner pursuant to an agreement with the authority responsible for
collecting the tax liability, unless the agency has considered suspension or
debarment of the corporation and made a determination that this further action is
not necessary to protect the interests of the Government.
4. Federal Funding Accountability and Transparency Act of 2006 (FFATA):
The FFATA and Public Law 109-282, which amends the FFATA, require full disclosure of all
entities and organizations that receive federal funds including awards, contracts, loans,
other assistance, and payments. This information must be submitted through the single,
publicly accessible website, www.USASpending.gov.
Compliance with these mandates is primarily the responsibility of the federal agency.
However, two elements of these mandates require information to be collected and
reported by applicants: 1) information on executive compensation when not already
reported through the System for Award Management; and 2) similar information on all
subawards, subcontracts, or consortiums for greater than $25,000.
For the full text of these requirements, see
www.gpo.gov/fdsys/browse/collection.action?collectionCode=BILLS.
Page 44
G. Agency Contacts
CDC encourages inquiries concerning this FOA.
For programmatic technical assistance, contact:
Kimball F. Credle
Project Officer
Division of Emergency and Environmental Health Services
National Center for Environmental Health, CDC
Email: [email protected]
Office phone: (770) 488-3643
For financial, awards management, or budget assistance, contact:
Glynnis Taylor, Grants Management Specialist
Department of Health and Human Services
CDC Procurement and Grants Office
2920 Brandywine Road, MS K69
Atlanta, GA 30341
Telephone: 770-488-2752
Email: [email protected]
For assistance with submission difficulties related to www.grants.gov, contact the Contact
Center by phone at 1-800-518-4726.
Hours of Operation: 24 hours a day, 7 days a week, except on federal holidays.
For all other submission questions, contact:
Technical Information Management Section
Department of Health and Human Services
CDC Procurement and Grants Office
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700
E-mail: [email protected]
CDC Telecommunications for persons with hearing loss is available at TTY 1-888-232-6348.
Page 45
H. Other Information
CDC/NCEH/Lead website: www.cdc.gov/nceh/lead/about/program.htm
Following is a list of acceptable attachments that applicants can upload as PDF files as part
of their applications at www.grants.gov. Applicants may not attach documents other than
those listed; if other documents are attached, applications will not be reviewed.
Project Abstract
Project Narrative
Budget Narrative
CDC Assurances and Certifications
Work Plan
Table of Contents for Entire Submission
Resumes/CVs
Organizational Charts
Nonprofit Organization IRS Status Forms, if applicable
Indirect Cost Rate, if applicable
Memorandum of Agreement (MOA)
Memorandum of Understanding (MOU)
Bona Fide Agent Status Documentation, if applicable
I. Glossary
CDC may add to glossary.
Administrative and National Policy Requirements, Additional Requirements (ARs):
Administrative requirements found in 45 CFR Part 74 and Part 92 and other requirements
mandated by statute or CDC policy. All ARs are listed in the Template for CDC programs. CDC
programs must indicate which ARs are relevant to the FOA; awardees must comply with the ARs
listed in the FOA. To view brief descriptions of relevant provisions, see
www.cdc.gov/od/pgo/funding/grants/additional_req.shtm.
Award: Financial assistance that provides support or stimulation to accomplish a public
purpose. Awards include grants and other agreements (e.g., cooperative agreements) in the
form of money, or property in lieu of money, by the federal government to an eligible
applicant.
Budget Period or Budget Year: The duration of each individual funding period within the
Page 46
project period. Traditionally, budget periods are 12 months or 1 year.
Carryover: Unobligated federal funds remaining at the end of any budget period that, with the
approval of the GMO or under an automatic authority, may be carried over to another budget
period to cover allowable costs of that budget period either as an offset or additional
authorization. Obligated but liquidated funds are not considered carryover.
Catalog of Federal Domestic Assistance (CFDA): A catalog published twice a year that describes
domestic assistance programs administered by the federal government. This catalog lists
projects, services, and activities that provide assistance or benefits to the American public. This
catalog is available at
https://www.cfda.gov/index?s=agency&mode=form&id=0bebbc3b3261e255dc82002b8309471
7&tab=programs&tabmode=list&subtab=list&subtabmode=list.
CFDA Number: A unique number assigned to each program and FOA throughout its lifecycle
that enables data and funding tracking and transparency.
CDC Assurances and Certifications: Standard government-wide grant application forms.
Competing Continuation Award: A financial assistance mechanism that adds funds to a grant
and adds one or more budget periods to the previously established project period (i.e., extends
the “life” of the award).
Continuous Quality Improvement: A system that seeks to improve the provision of services
with an emphasis on future results.
Contracts: An award instrument that establishes a binding, legal procurement relationship
between CDC and a recipient and obligates the recipient to furnish a product.
Cooperative Agreement: A financial assistance award with the same kind of interagency
relationship as a grant except that it provides for substantial involvement by the federal agency
funding the award.
Cost Sharing or Matching: Refers to program costs not borne by the federal government but by
the awardees. It may include the value of allowable third-party, in-kind contributions, as well as
expenditures by the awardee.
Direct Assistance: An assistance support mechanism, which must be specifically authorized by
statute, whereby goods or services are provided to recipients in lieu of cash. Direct assistance
generally involves the assignment of federal personnel or the provision of equipment or
supplies, such as vaccines (http://intranet.cdc.gov/ostlts/directassistance/index.html).
DUNS: The Dun and Bradstreet Data Universal Numbering System (DUNS) number is a ninePage 47
digit number assigned by Dun and Bradstreet Information Services. When applying for federal
awards or cooperative agreements, all applicant organizations must obtain a DUNS number as
the universal identifier. DUNS number assignment is free. If requested by telephone, a DUNS
number will be provided immediately at no charge. If requested via the internet, obtaining a
DUNS number may take one to two days at no charge. If an organization does not know its
DUNS number or needs to register for one, visit Dun & Bradstreet at
http://fedgov.dnb.com/webform/displayHomePage.do.
Federal Funding Accountability and Transparency Act of 2006 (FFATA): Requires that
information about federal awards, including awards, contracts, loans, and other assistance and
payments, be available to the public on a single website at www.USAspending.gov.
Fiscal Year: The year for which budget dollars are allocated annually. The federal fiscal year
starts October 1 and ends September 30.
Grant: A legal instrument used by the federal government to transfer anything of value to a
recipient for public support or stimulation authorized by statute. Financial assistance may be
money or property. The definition does not include a federal procurement subject to the
Federal Acquisition Regulation; technical assistance (which provides services instead of money);
or assistance in the form of revenue sharing, loans, loan guarantees, interest subsidies,
insurance, or direct payments of any kind to a person or persons. The main difference between
a grant and a cooperative agreement is that in a grant there is no anticipated substantial
programmatic involvement by the federal government under the award.
Grants.gov: A “storefront” web portal for electronic data collection (forms and reports) for
federal grant-making agencies at www.grants.gov.
Health Disparities: Differences in health outcomes and their determinants among segments of
the population as defined by social, demographic, environmental, or geographic category.
Healthy People 2020: National health objectives aimed at improving the health of all Americans
by encouraging collaboration across sectors, guiding people toward making informed health
decisions, and measuring the effects of prevention activities.
Inclusion: Both the meaningful involvement of a community’s members in all stages of the
program process and the maximum involvement of the target population that the intervention
will benefit. Inclusion ensures that the views, perspectives, and needs of affected communities,
care providers, and key partners are considered.
Indirect Costs: Costs that are incurred for common or joint objectives and not readily and
specifically identifiable with a particular sponsored project, program, or activity; nevertheless,
these costs are necessary to the operations of the organization. For example, the costs of
operating and maintaining facilities, depreciation, and administrative salaries generally are
Page 48
considered indirect costs.
Intergovernmental review: Executive Order 12372 governs applications subject to
Intergovernmental Review of Federal Programs. This order sets up a system for state and local
governmental review of proposed federal assistance applications. Contact the state single point
of contact (SPOC) to alert the SPOC to prospective applications and to receive instructions on
the State’s process. Visit the following web address to get the current SPOC list:
www.whitehouse.gov/omb/grants_spoc/.
Letter of Intent (LOI): A preliminary, nonbinding indication of an organization’s intent to submit
an application.
Lobbying: Direct lobbying includes any attempt to influence legislation, appropriations,
regulations, administrative actions, executive orders (legislation or other orders), or other
similar deliberations at any level of government through communication that directly expresses
a view on proposed or pending legislation or other orders, and which is directed to staff
members or other employees of a legislative body, government officials, or employees who
participate in formulating legislation or other orders. Grassroots lobbying includes efforts
directed at inducing or encouraging members of the public to contact their elected
representatives at the federal, state, or local levels to urge support of, or opposition to,
proposed or pending legislative proposals.
Maintenance of Effort: A requirement contained in authorizing legislation or applicable
regulations that a recipient must agree to contribute and maintain a specified level of financial
effort from its own resources or other nongovernment sources to be eligible to receive federal
grant funds. This requirement is typically given in terms of meeting a previous base-year dollar
amount.
Memorandum of Understanding (MOU) or Memorandum of Agreement (MOA): Document
that describes a bilateral or multilateral agreement between parties expressing a convergence
of will between the parties, indicating an intended common line of action. It is often used in
cases where the parties either do not imply a legal commitment or cannot create a legally
enforceable agreement.
New FOA: Any FOA that is not a continuation or supplemental award.
Nongovernment Organization (NGO): Any nonprofit, voluntary citizens’ group that is organized
on a local, national, or international level.
Notice of Award (NoA): The only binding, authorizing document between the recipient and CDC
that confirms issue of award funding. The NoA will be signed by an authorized GMO and
provided to the recipient fiscal officer identified in the application.
Performance Measurement: The ongoing monitoring and reporting of program
Page 49
accomplishments, particularly progress toward pre-established goals, typically conducted by
program or agency management. Performance measurement may address the type or level of
program activities conducted (process), the direct products and services delivered by a program
(outputs), or the results of those products and services (outcomes). A “program” may be any
activity, project, function, or policy that has an identifiable purpose or set of objectives.
Objective Review: A process that involves the thorough and consistent examination of
applications based on an unbiased evaluation of scientific or technical merit or other relevant
aspects of the proposal. The review is intended to provide advice to the persons responsible for
making award decisions.
Outcome: The observable benefits or changes for populations or public health capabilities that
will result from a particular program strategy.
Plain Writing Act of 2010: Requires federal agencies to communicate with the public in plain
language to make information more accessible and understandable by intended users,
especially people with limited health literacy skills or limited English proficiency. The Plain
Writing Act is available at www.plainlanguage.gov.
Program Strategies: Public health interventions or public health capabilities.
Program Official: Person responsible for developing the FOA; can be a project officer, program
manager, branch chief, division leader, policy official, center leader, or similar staff member.
Project Period Outcome: An outcome that will occur by the end of the FOA'’s funding period.
Public Health Accreditation Board (PHAB): National, nonprofit organization that improves
tribal, state, local, territorial, and U.S. public health departments and strengthens their quality
and performance through accreditation.
System for Award Management (SAM): The primary vendor database for the U.S. federal
government. SAM validates applicant information and electronically shares secure and
encrypted data with federal agencies' finance offices to facilitate paperless payments through
Electronic Funds Transfer (EFT). SAM stores organizational information, allowing
www.grants.gov to verify identity and prefill organizational information on grant applications.
Statute: An act of the legislature; a particular law enacted and established by the will of the
legislative department of government, expressed with the requisite formalities. In foreign or
civil law any particular municipal law or usage, though resting for its authority on judicial
decisions, or the practice of nations. Black’s Law Dictionary 2 Kent, Comma 450.
Statutory Authority: Authority provided by legal statute that establishes a federal financial
assistance program or award.
Page 50
Technical Assistance: Advice, assistance, or training pertaining to program development,
implementation, maintenance, or evaluation that is provided by the funding agency.
Work Plan: The summary of annual strategies and activities, personnel and/or partners who
will complete them, and the timeline for completion. The work plan will outline the details of all
necessary activities that will be supported through the approved budget.
Page 51
| File Type | application/pdf |
| File Title | Domestic - FY 2014 Template for Non-research FOA |
| Subject | (New, non-research, domestic) |
| Author | Type the author name |
| File Modified | 2014-06-19 |
| File Created | 2014-06-19 |